INTERNATIONAL PATENT: OMASS THERAPEUTICS LIMITED FILES APPLICATION FOR "1H-PYRIDAZINO[4,3-E][1,3,4]THIADIAZINE AND SPIRO[CYCLOPROPANE-1,5'-PYRIDAZINO[4,3-E][1,3]THIAZINE] DERIVATIVES AS GPR65 AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES"

GENEVA, Nov. 24 -- OMASS THERAPEUTICS LIMITED (Building 4000 John Smith Drive, Oxford Business Park SouthOxford OX4 2GX) filed a patent application (PCT/GB2025/051028) for "1H-PYRIDAZINO[4,3-E][1,3,4]THIADIAZINE AND SPIRO[CYCLOPROPANE-1,5'-PYRIDAZINO[4,3-E][1,3]THIAZINE] DERIVATIVES AS GPR65 AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES" on May 13, 2025. With publication no. WO/2025/238350, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROFFEY, Jonathan Richard Anthony (c/o Building 4000 John Smith Drive, Oxford Bu...